Press release
Angiotensin Receptor Blockers (ARBs) Market size, Share, Trends, Drivers And Forecast 2023-2032
Angiotensin Receptor Blockers (ARBs) Market Report
The Business Research Company's Angiotensin Receptor Blockers (ARBs) Global Market Report 2023 identifies the increasing incidence of cardiovascular diseases as the major driver for the angiotensin receptor blockers (ARBs) market's growth in the forecast period. It is frequently associated with the development of fatty deposits within the arteries (atherosclerosis) and an increased risk of blood clots. By assisting in vein and artery relaxation, angiotensin receptor blockers lower blood pressure and facilitate the heart's ability to pump blood, which can reduce cardiovascular diseases.
The global angiotensin receptor blockers (ARBs) market size is expected to grow from $8.02 billion in 2022 to $8.30 billion in 2023 at a compound annual growth rate (CAGR) of 3.5%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global angiotensin receptor blockers (ARBs) market size is expected to grow to $9.40 billion in 2027 at a CAGR of 3.2%.
Download Free Sample Of Angiotensin Receptor Blockers (ARBs) Market Report -
https://www.thebusinessresearchcompany.com/sample.aspx?id=8943&type=smp
Major competitors in the angiotensin receptor blockers (ARBs) market are Pfizer Inc., Novartis AG, Merck & Co. Inc., AstraZeneca Plc., Bristol-Myers Squibb Company.
A key trend in the angiotensin receptor blockers (ARBs) market includes product innovation. Major companies operating in the angiotensin receptor blocker market are focused on developing innovative solutions to strengthen their position in the market. For instance, in February 2021, Novartis AG, a Switzerland-based pharmaceutical company, launched Entresto (sacubitril/valsartan). Entresto (sacubitril/valsartan) has been granted an expanded indication by the United States Food and Drug Administration to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure.
Read More On The Global Angiotensin Receptor Blockers (ARBs) Market Report Here:
https://www.thebusinessresearchcompany.com/report/angiotensin-receptor-blockers-arbs-global-market-report
The angiotensin receptor blockers (ARBs) market is segmented -
•By Product: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan
•By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications
•By End User: Hospitals, Specialty Clinics, Ambulatory Surgical Centers
•By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the angiotensin receptor blockers (ARBs) market.
The Business Research Company's "Global Angiotensin Receptor Blockers (ARBs) Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.
Explore Buying Options For The Angiotensin Receptor Blockers (ARBs) Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8943
The Table Of Content For The Angiotensin Receptor Blockers (ARBs) Market Include:
1. Executive Summary
2. Angiotensin Receptor Blockers (ARBs) Market Characteristics
3. Angiotensin Receptor Blockers (ARBs) Market Trends And Strategies
4. Angiotensin Receptor Blockers (ARBs) Market - Macro Economic Scenario
5. Angiotensin Receptor Blockers (ARBs) Market Size And Growth
……
26. Africa Angiotensin Receptor Blockers (ARBs) Market
27. Angiotensin Receptor Blockers (ARBs) Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Angiotensin Receptor Blockers (ARBs) Market
29. Angiotensin Receptor Blockers (ARBs) Market Future Outlook and Potential Analysis
30. Appendix
Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx
Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.
Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Angiotensin Receptor Blockers (ARBs) Market size, Share, Trends, Drivers And Forecast 2023-2032 here
News-ID: 3206645 • Views: …
More Releases from The Business Research Company
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025?
The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of…
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate…
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025?
In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in…
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025?
In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic…
More Releases for ARBs
Angiotensin Receptor Blockers (ARBs) Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Angiotensin Receptor Blockers (ARBs) Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The Angiotensin Receptor Blockers (ARBs) market has been expanding steadily due to their widespread use in the treatment of hypertension, heart failure, and…
Angiotensin Receptor Blockers (ARBs) Market Current Status and Future Prospects …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Angiotensin Receptor Blockers (ARBs) Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key…
Angiotensin Receptor Blockers (ARBs) Market Trends, Strategies, Size, Share And …
"The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Angiotensin Receptor Blockers (ARBs) Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $10.28 billion In…
Angiotensin Receptor Blockers (Arbs) Market Size, Share, Growth Report 2023
The global angiotensin receptor blockers (arbs) market size was valued at USD 8,049.9 million in 2022 and is poised to grow at a significant CAGR of 3.9% during the forecast period 2023-29. The primary drivers of the expansion of the global angiotensin receptor blockers market include the increasing prevalence of cardiovascular diseases and chronic kidney disorders. In addition, increasing geriatric population is expected to boost the growth of angiotensin receptor…
Angiotensin Receptor Blockers (ARBs) Market 2022 | Detailed Report
The top-notch information research report published by markets and markets is a vital asset that offers qualitative and quantitative factors of the Angiotensin Receptor Blockers (ARBs) market. The research study and methodologies mentioned in the report examine the critical vendors by considering their contribution to the global market. Furthermore, the report offers an in-depth insight into leading players' performance based on revenue generation and client requirements. Also, the research report…
Angiotensin II Receptor Blocker (ARBs) API Market To Upscale Amidst Technologica …
The professional intelligence report presents a comprehensive evaluation of various factors that may influence the future performance of the Global Angiotensin II Receptor Blocker (ARBs) API Market during the forecast period of 2021 to 2027. It highlights a host of interlinked factors that may create promising growth opportunities in the global Angiotensin II Receptor Blocker (ARBs) API market in coming years. It also provides holistic perspective regarding different trends that…
